Claude's enzyme discovery claim meets skepticism from CRISPR researchers
Anthropic's Claude performed autonomous analysis on genomic databases to identify a previously unknown enzyme system, marking a shift in how LLMs tackle specialized scientific discovery. However, the claim faces pushback from CRISPR researchers who characterize the finding as standard bioinformatics work rather than genuine discovery. The tension highlights a recurring pattern in AI hype: frontier labs overselling model contributions to domain-specific tasks while domain experts remain skeptical of the novelty. This matters because it tests whether LLMs can credibly claim scientific breakthroughs or whether they remain powerful tools for accelerating routine analysis.
Modelwire context
Skeptical readThe real tension isn't whether Claude found something novel in the data, but whether autonomous database screening counts as scientific discovery at all. Anthropic's framing assumes novelty equals contribution; CRISPR researchers are saying novelty in a dataset is just what competent bioinformatics does.
This echoes a pattern we saw with Google's Gemini calling businesses last week. Both stories involve frontier labs claiming a capability shift (autonomous action, scientific reasoning) while glossing over what the system actually does differently from existing tools. With Gemini, the novelty was placing calls; the risk was liability and consent. Here, the novelty is supposedly discovery; the risk is that Anthropic is rebranding routine analysis as breakthrough science to justify model capabilities. The difference: Gemini's claim is harder to dispute because the call got placed. Claude's claim hinges on whether mining known databases for overlooked patterns is science or just search.
If the enzyme system Claude identified has already been published in peer-reviewed literature or appears in standard reference databases that Claude's training data likely covered, that confirms the skeptics. If independent CRISPR labs can reproduce the finding using standard bioinformatics tools (BLAST, InterProScan, existing pipelines) within two weeks, Anthropic's exclusive credit dissolves.
Coverage we drew on
This analysis is generated by Modelwire’s editorial layer from our archive and the summary above. It is not a substitute for the original reporting. How we write it.
MentionsAnthropic · Claude · The Decoder
Modelwire Editorial
This synthesis and analysis was prepared by the Modelwire editorial team. We use advanced language models to read, ground, and connect the day’s most significant AI developments, providing original strategic context that helps practitioners and leaders stay ahead of the frontier.
Modelwire summarizes, we don’t republish. The Decoder originally reported this story as “Anthropic says Claude discovered a new enzyme system, but CRISPR researchers call it routine genome mining”. The full content lives on the-decoder.com. If you’re a publisher and want a different summarization policy for your work, see our takedown page.